

HY-P99899 · 1 mg
MedChemExpress · Cat: HY-P99899
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/samrotamab.html
Description
Samrotamab PR-1498487 is a humanized IgG1-? chimeric antibody targeting LRRC15. Samrotamab markedly reduces bladder cancer cells viability and inhibits clonogenic growth, migratory and invasive capabilities. Samrotamab significantly increases LRRC15 mRNA level while suppressing SCG5 mRNA expression. Samrotamab can be used for synthesis of ADC ABBV-085.







